Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection
Status:
Completed
Trial end date:
2020-06-08
Target enrollment:
Participant gender:
Summary
This is a double-blind, randomized, placebo-controlled clinical trial. A total of 210
individuals aged over 18 years old, without a diagnosis of severe respiratory disease, who
came to the study site with clinical and radiological suspicion of SARS-CoV2, will be
randomized into two treatment groups at a 1:1 ratio to receive a 5-day CQ diphosphate tablets
or placebo (tablet without active ingredient produced with the same physical
characteristics).
Phase:
Phase 2
Details
Lead Sponsor:
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado